Inventor
SHAH MANDAR V
US47 patents
⚠️ This page may combine multiple inventors who share the name “SHAH MANDAR V”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SOMERSET THERAPEUTICS LLC
33 patentsUS11298368B2Apr 12, 2022
Efficient tobramycin compound conjugate compositions
SOMERSET THERAPEUTICS LLC1 citations73
US12156868B2Dec 3, 2024
Formulations of pilocarpine and brimonidine compounds and related methods
SOMERSET THERAPEUTICS LLC1 citations72
US11969410B2Apr 30, 2024
Low pH pilocarpine and brimonidine compound formulations and related methods
SOMERSET THERAPEUTICS LLC1 citations72
US11857539B2Jan 2, 2024
Gel ophthalmic formulations of pilocarpine and brimonidine compounds and related methods
SOMERSET THERAPEUTICS LLC1 citations72
US11564931B2Jan 31, 2023
Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation properties
SOMERSET THERAPEUTICS LLC1 citations72
US11400100B2Aug 2, 2022
Effective benzalkonium chloride-free bimatoprost ophthalmic compositions
SOMERSET THERAPEUTICS LLC1 citations72
US11298315B2Apr 12, 2022
Triamcinolone and moxifloxacin compositions
SOMERSET THERAPEUTICS LLC3 citations72
US11478491B2Oct 25, 2022
Tobramycin compound-copolymer conjugates and derivative compositions
SOMERSET THERAPEUTICS LLC1 citations71
US11478492B2Oct 25, 2022
Tobramycin compound conjugate formulations
SOMERSET THERAPEUTICS LLC1 citations71
US12343373B2Jul 1, 2025
Glycopeptide antibiotics liquid formulations and methods and uses thereof
SOMERSET THERAPEUTICS LLC0 citations62
US12064440B2Aug 20, 2024
Ophthalmic gel compositions of bimatoprost and timolol and associated methods
SOMERSET THERAPEUTICS LLC0 citations62
US12042502B2Jul 23, 2024
Enhanced penetration ophthalmic compositions of bimatoprost and timolol
SOMERSET THERAPEUTICS LLC0 citations62
US12016855B2Jun 25, 2024
Prednisolone and moxifloxacin compositions and methods
SOMERSET THERAPEUTICS LLC0 citations62
US11786538B2Oct 17, 2023
Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation properties
SOMERSET THERAPEUTICS LLC0 citations62
US11510930B2Nov 29, 2022
Gatifloxacin, prednisolone, and bromfenac compositions and methods
SOMERSET THERAPEUTICS LLC0 citations62
US11484538B2Nov 1, 2022
Bromfenac, prednisolone, and moxifloxacin compositions and methods
SOMERSET THERAPEUTICS LLC0 citations62
US11471403B2Oct 18, 2022
Limited particle size triamcinolone and moxifloxacin compositions and associated methods of use
SOMERSET THERAPEUTICS LLC0 citations62
US11446242B2Sep 20, 2022
Suspension component-specific triamcinolone and moxifloxacin compositions and associated methods of use
SOMERSET THERAPEUTICS LLC0 citations62
US11439591B2Sep 13, 2022
Moxifloxacin and triamcinolone compositions and associated methods
SOMERSET THERAPEUTICS LLC0 citations62
US11433115B2Sep 6, 2022
Glycopeptide antibiotics liquid formulations and methods and uses thereof
SOMERSET THERAPEUTICS LLC1 citations62
US11382910B2Jul 12, 2022
Loteprednol and moxifloxacin compositions and methods
SOMERSET THERAPEUTICS LLC0 citations62
US11344566B2May 31, 2022
Tobramycin compound conjugates and derivative compositions
SOMERSET THERAPEUTICS LLC0 citations62
US11590153B2Feb 28, 2023
Methods of treating eye disease with tobramycin-related compositions
SOMERSET THERAPEUTICS LLC0 citations61
US11523987B2Dec 13, 2022
Trimcinolone and moxifloxacin methods
SOMERSET THERAPEUTICS LLC0 citations61
US11395831B2Jul 26, 2022
Combination products of tobramycin compounds and dexameihasone compounds
SOMERSET THERAPEUTICS LLC0 citations61
US11883382B2Jan 30, 2024
Buffer-free ophthalmological compositions of ketorolac and phenylephrine and applications thereof
SOMERSET THERAPEUTICS LLC0 citations60
US11793789B2Oct 24, 2023
Treatment of ophthalmological conditions using buffer-free ophthalmological compositions of ketorolac and phenylephrine
SOMERSET THERAPEUTICS LLC0 citations60
US11696910B2Jul 11, 2023
Buffer-free, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereof
SOMERSET THERAPEUTICS LLC1 citations60
US11400068B2Aug 2, 2022
Liquid ready-to-use formulation of levothyroxine
SOMERSET THERAPEUTICS LLC0 citations57
US12102632B2Oct 1, 2024
Quinolone dispersions
SOMERSET THERAPEUTICS LLC0 citations51
US11857538B2Jan 2, 2024
Stable pilocarpine formulations with modified buffer characteristics and related methods
SOMERSET THERAPEUTICS LLC0 citations51
US11850249B2Dec 26, 2023
Methods of efficiently reducing intraocular pressure
SOMERSET THERAPEUTICS LLC0 citations51
US12029729B2Jul 9, 2024
Chelated, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereof
SOMERSET THERAPEUTICS LLC0 citations50
SENTISS PHARMA PRIVATE LTD
6 patentsUS11285163B2Mar 29, 2022
Ophthalmic solution
SENTISS PHARMA PRIVATE LTD7 citations83
US10517869B2Dec 31, 2019
Topical brimonidine tartrate ophthalmic solution
SENTISS PHARMA PRIVATE LTD2 citations71
US11826429B2Nov 28, 2023
Pharmaceutical composition comprising brinzolamide
SENTISS PHARMA PRIVATE LTD1 citations60
US10632198B2Apr 28, 2020
Pharmaceutical composition comprising brinzolamide
SENTISS PHARMA PRIVATE LTD1 citations60
US9801813B2Oct 31, 2017
Preservative-free ophthalmic pharmaceutical formulation
SENTISS PHARMA PRIVATE LTD0 citations39
US10463674B2Nov 5, 2019
Process for manufacturing sterile ophthalmic pharmaceutical suspensions
SENTISS PHARMA PRIVATE LTD0 citations34
ALCON INC
4 patentsUS7084130B2Aug 1, 2006
Intraocular irrigating solution having improved flow characteristics
ALCON INC8 citations73
US7169755B2Jan 30, 2007
Solution for removing cataracts via liquefracture
ALCON INC4 citations62
US7578809B2Aug 25, 2009
Surface modified viscoelastics for ocular surgery
ALCON INC1 citations52
US7363928B2Apr 29, 2008
Dilution resistant viscoelastic compositions
ALCON INC1 citations52